DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue

Sari Jäämaa, Taija M. Af Hällström, Anna Sankila, Ville Rantanen, Hannu Koistinen, Ulf Håkan Stenman, Zhewei Zhang, Zhiming Yang, Angelo Michael Demarzo, Kimmo Taari, Mirja Ruutu, Leif C. Andersson, Marikki Laiho

Research output: Contribution to journalArticle

Abstract

DNA damage response (DDR) pathways have been extensively studied in cancer cell lines and mouse models, but little is known about how DNA damage is recognized by different cell types in nonmalignant, slowly replicating human tissues. Here, we assess, using ex vivo cultures of human prostate tissue, DDR caused by cytotoxic drugs (camptothecin, doxorubicin, etoposide, and cisplatin) and ionizing radiation (IR) in the context of normal tissue architecture. Using specific markers for basal and luminal epithelial cells, we determine and quantify cell compartment-specific damage recognition. IR, doxorubicin, and etoposide induced the phosphorylation of H2A.X on Ser139 (γH2AX) and DNA damage foci formation. Surprisingly, luminal epithelial cells lack the prominent γH2AX response after IR when compared with basal cells, although ATM phosphorylation on Ser1981 and 53BP1 foci were clearly detectable in both cell types. The attenuated γH2AX response seems to result from low levels of total H2A.X in the luminal cells. Marked increase in p53, a downstream target of the activated ATM pathway, was detected only in response to camptothecin and doxorubicin. These findings emphasize the diversity of pathways activated by DNA damage in slowly replicating tissues and reveal an unexpected deviation in the prostate luminal compartment that may be relevant in prostate tumorigenesis. Detailed mapping of tissue and cell type differences in DDR will provide an outlook of relevant responses to therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)8630-8641
Number of pages12
JournalCancer Research
Volume70
Issue number21
DOIs
StatePublished - Nov 1 2010

Fingerprint

DNA Damage
Prostate
Ionizing Radiation
Doxorubicin
Camptothecin
Etoposide
Epithelial Cells
Phosphorylation
Cisplatin
Carcinogenesis
Cell Line
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Jäämaa, S., Af Hällström, T. M., Sankila, A., Rantanen, V., Koistinen, H., Stenman, U. H., ... Laiho, M. (2010). DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue. Cancer Research, 70(21), 8630-8641. https://doi.org/10.1158/0008-5472.CAN-10-0937

DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue. / Jäämaa, Sari; Af Hällström, Taija M.; Sankila, Anna; Rantanen, Ville; Koistinen, Hannu; Stenman, Ulf Håkan; Zhang, Zhewei; Yang, Zhiming; Demarzo, Angelo Michael; Taari, Kimmo; Ruutu, Mirja; Andersson, Leif C.; Laiho, Marikki.

In: Cancer Research, Vol. 70, No. 21, 01.11.2010, p. 8630-8641.

Research output: Contribution to journalArticle

Jäämaa, S, Af Hällström, TM, Sankila, A, Rantanen, V, Koistinen, H, Stenman, UH, Zhang, Z, Yang, Z, Demarzo, AM, Taari, K, Ruutu, M, Andersson, LC & Laiho, M 2010, 'DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue', Cancer Research, vol. 70, no. 21, pp. 8630-8641. https://doi.org/10.1158/0008-5472.CAN-10-0937
Jäämaa S, Af Hällström TM, Sankila A, Rantanen V, Koistinen H, Stenman UH et al. DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue. Cancer Research. 2010 Nov 1;70(21):8630-8641. https://doi.org/10.1158/0008-5472.CAN-10-0937
Jäämaa, Sari ; Af Hällström, Taija M. ; Sankila, Anna ; Rantanen, Ville ; Koistinen, Hannu ; Stenman, Ulf Håkan ; Zhang, Zhewei ; Yang, Zhiming ; Demarzo, Angelo Michael ; Taari, Kimmo ; Ruutu, Mirja ; Andersson, Leif C. ; Laiho, Marikki. / DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue. In: Cancer Research. 2010 ; Vol. 70, No. 21. pp. 8630-8641.
@article{7683cf9b05a747db9df9d87660be29a9,
title = "DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue",
abstract = "DNA damage response (DDR) pathways have been extensively studied in cancer cell lines and mouse models, but little is known about how DNA damage is recognized by different cell types in nonmalignant, slowly replicating human tissues. Here, we assess, using ex vivo cultures of human prostate tissue, DDR caused by cytotoxic drugs (camptothecin, doxorubicin, etoposide, and cisplatin) and ionizing radiation (IR) in the context of normal tissue architecture. Using specific markers for basal and luminal epithelial cells, we determine and quantify cell compartment-specific damage recognition. IR, doxorubicin, and etoposide induced the phosphorylation of H2A.X on Ser139 (γH2AX) and DNA damage foci formation. Surprisingly, luminal epithelial cells lack the prominent γH2AX response after IR when compared with basal cells, although ATM phosphorylation on Ser1981 and 53BP1 foci were clearly detectable in both cell types. The attenuated γH2AX response seems to result from low levels of total H2A.X in the luminal cells. Marked increase in p53, a downstream target of the activated ATM pathway, was detected only in response to camptothecin and doxorubicin. These findings emphasize the diversity of pathways activated by DNA damage in slowly replicating tissues and reveal an unexpected deviation in the prostate luminal compartment that may be relevant in prostate tumorigenesis. Detailed mapping of tissue and cell type differences in DDR will provide an outlook of relevant responses to therapeutic strategies.",
author = "Sari J{\"a}{\"a}maa and {Af H{\"a}llstr{\"o}m}, {Taija M.} and Anna Sankila and Ville Rantanen and Hannu Koistinen and Stenman, {Ulf H{\aa}kan} and Zhewei Zhang and Zhiming Yang and Demarzo, {Angelo Michael} and Kimmo Taari and Mirja Ruutu and Andersson, {Leif C.} and Marikki Laiho",
year = "2010",
month = "11",
day = "1",
doi = "10.1158/0008-5472.CAN-10-0937",
language = "English (US)",
volume = "70",
pages = "8630--8641",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "21",

}

TY - JOUR

T1 - DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue

AU - Jäämaa, Sari

AU - Af Hällström, Taija M.

AU - Sankila, Anna

AU - Rantanen, Ville

AU - Koistinen, Hannu

AU - Stenman, Ulf Håkan

AU - Zhang, Zhewei

AU - Yang, Zhiming

AU - Demarzo, Angelo Michael

AU - Taari, Kimmo

AU - Ruutu, Mirja

AU - Andersson, Leif C.

AU - Laiho, Marikki

PY - 2010/11/1

Y1 - 2010/11/1

N2 - DNA damage response (DDR) pathways have been extensively studied in cancer cell lines and mouse models, but little is known about how DNA damage is recognized by different cell types in nonmalignant, slowly replicating human tissues. Here, we assess, using ex vivo cultures of human prostate tissue, DDR caused by cytotoxic drugs (camptothecin, doxorubicin, etoposide, and cisplatin) and ionizing radiation (IR) in the context of normal tissue architecture. Using specific markers for basal and luminal epithelial cells, we determine and quantify cell compartment-specific damage recognition. IR, doxorubicin, and etoposide induced the phosphorylation of H2A.X on Ser139 (γH2AX) and DNA damage foci formation. Surprisingly, luminal epithelial cells lack the prominent γH2AX response after IR when compared with basal cells, although ATM phosphorylation on Ser1981 and 53BP1 foci were clearly detectable in both cell types. The attenuated γH2AX response seems to result from low levels of total H2A.X in the luminal cells. Marked increase in p53, a downstream target of the activated ATM pathway, was detected only in response to camptothecin and doxorubicin. These findings emphasize the diversity of pathways activated by DNA damage in slowly replicating tissues and reveal an unexpected deviation in the prostate luminal compartment that may be relevant in prostate tumorigenesis. Detailed mapping of tissue and cell type differences in DDR will provide an outlook of relevant responses to therapeutic strategies.

AB - DNA damage response (DDR) pathways have been extensively studied in cancer cell lines and mouse models, but little is known about how DNA damage is recognized by different cell types in nonmalignant, slowly replicating human tissues. Here, we assess, using ex vivo cultures of human prostate tissue, DDR caused by cytotoxic drugs (camptothecin, doxorubicin, etoposide, and cisplatin) and ionizing radiation (IR) in the context of normal tissue architecture. Using specific markers for basal and luminal epithelial cells, we determine and quantify cell compartment-specific damage recognition. IR, doxorubicin, and etoposide induced the phosphorylation of H2A.X on Ser139 (γH2AX) and DNA damage foci formation. Surprisingly, luminal epithelial cells lack the prominent γH2AX response after IR when compared with basal cells, although ATM phosphorylation on Ser1981 and 53BP1 foci were clearly detectable in both cell types. The attenuated γH2AX response seems to result from low levels of total H2A.X in the luminal cells. Marked increase in p53, a downstream target of the activated ATM pathway, was detected only in response to camptothecin and doxorubicin. These findings emphasize the diversity of pathways activated by DNA damage in slowly replicating tissues and reveal an unexpected deviation in the prostate luminal compartment that may be relevant in prostate tumorigenesis. Detailed mapping of tissue and cell type differences in DDR will provide an outlook of relevant responses to therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=78449270063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78449270063&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-10-0937

DO - 10.1158/0008-5472.CAN-10-0937

M3 - Article

C2 - 20978201

AN - SCOPUS:78449270063

VL - 70

SP - 8630

EP - 8641

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 21

ER -